Related Experiment Video
Updated: Jul 4, 2026
10:24
A High Throughput in situ Hybridization Method to Characterize mRNA Expression Patterns in the Fetal Mouse Lower Urogenital Tract
Published on: August 19, 2011
Microarray study of gene expression in uterine leiomyoma.
K V Litovkin1, O V Ivanova, A Bauer
1Institute of Molecular and Cellular Medicine, Odessa State Medical University, Odessa, Ukraine. k.litovkin@rambler.ru
Experimental Oncology
|June 21, 2008
Summary
Researchers identified novel genes involved in uterine leiomyoma development. These findings offer potential new diagnostic markers and therapeutic targets for this common condition in women.
Area of Science:
- Gynecologic Oncology
- Molecular Biology
- Genetics
Background:
- Uterine leiomyoma is a prevalent benign neoplasm affecting women of reproductive age.
- These tumors originate from the uterine myometrium and can potentially become malignant.
Purpose of the Study:
- To identify genes implicated in the pathogenesis of uterine leiomyoma.
- To discover novel molecular markers for diagnosis and therapy.
Main Methods:
- Differential gene expression analysis using cDNA microarray screening.
- Comparison of gene expression data with previously published microarray studies.
Main Results:
- Identified two groups of deregulated genes: novel genes (e.g., CLDN1, FGF7, MAPK12) and previously reported genes (e.g., CCND1, CDKN1A, FN1).
- Fibronectin 1 (FN1) was the most significantly upregulated gene in leiomyoma tissues compared to normal myometrium.
Conclusions:
- Newly identified genes represent potential diagnostic and prognostic markers for uterine leiomyoma.
- These genes may serve as valuable therapeutic targets for future treatment strategies.
